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ABSTRACT
Numerous physiological conditions and emotionally motivated behaviors require con-
comitant activation of somatomotor and sympathetic efferents. Using a virally mediated
retrograde transsynaptic tract-tracing approach, we have previously determined locations of
presympathetic-premotor neurons (PSPMNs) in the rat brainstem. These putative dual-
function neurons send projections to somatomotor and sympathetic targets and likely par-
ticipate in sympatho-somatomotor integration. A significant portion of these neurons is found
within brainstem areas known to contain serotonergic neurons. Thus, we hypothesized that
some of the PSPMNs utilize serotonin as their neurotransmitter. To test this hypothesis we
first produced an antibody against TPH2, a brain-specific isoform of tryptophan hydroxylase
(serotonin synthetic enzyme). We identified PSPMNs by using recombinant strains of the
pseudorabies virus (PRV) for transsynaptic tract-tracing. PRV-152, a strain that expresses
enhanced green fluorescent protein, was injected into sympathectomized gastrocnemius
muscle, while PRV-BaBlu, which expresses -galactosidase, was injected into the adrenal
gland in the same animals. Using immunofluorescent methods we determined whether
coinfected neurons expressed TPH2. Our findings demonstrate that TPH2-positive PSPMNs
are present at different rostrocaudal levels of the brainstem. Just over half of them are found
at the pontomedullary junction within raphe obscurus, raphe magnus, and gigantocellular
nucleus pars alpha. These cells may play a role in mediating responses to acute pain stimuli
and/or participate in the central control of exercise. Overactivity of these serotonergic
sympatho-somatomotor circuits may also play a role in the pathophysiology of serotonin
syndrome. J. Comp. Neurol. 499:882–896, 2006. © 2006 Wiley-Liss, Inc.
Indexing terms: tryptophan hydroxylase; sympatho-somatomotor integration; somatomotor
control; central autonomic circuits; Pseudorabies virus; ventromedial medulla
A wide range of human and animal behaviors are char-
acterized by coordinated activation or inhibition of the
activity of somatomotor efferents and that of the sympa-
thetic nervous system. Such behaviors can be divided into
several categories, including those that: 1) support daily
physiological functions of the organism, 2) are part of
motivated behaviors, and 3) are part of emotionally driven
responses. Examples of behaviors in the first category
include locomotion, exercise, cold defense, and sleep. Each
of these behaviors is characterized by a specific and coor-
dinated pattern of sympathetic and somatomotor activity.
In the case of locomotion, or other forms of exercise, the
onset of rhythmic somatomotor discharge is accompanied
by an immediate increase in respiratory function as well
as increases in heart rate, stroke volume, cardiac output,
peripheral resistance, and blood pressure to improve oxy-
gen delivery to contracting muscles (Waldrop et al., 1996).
Likewise, cold defense is characterized by increased shiv-
ering together with an increase in activity of sympathetic
nerves innervating brown adipose tissue (Morrison, 2004).
Motivated behaviors are likewise characterized by so-
matomotor and autonomic activation, such as during feed-
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ing behavior when activation of visceral efferents to the
gut needs to be coordinated with that of the somatomotor
efferents innervating muscles of mastication (Sutcliffe
and de Lecea, 2000). Furthermore, emotionally motivated
behaviors are characterized by concomitant recruitment of
somatomotor and sympathetic efferents. For example,
aggressive/defensive behavior may be characterized by
hissing, alerting, turning of the head, and kicking or strik-
ing together with increases in blood pressure and heart
rate as well as complementary redistribution of systemic
blood flow (Mancia and Zanchetti, 1981; Hilton, 1982;
Jordan, 1990).
Despite such compelling behavioral examples, tradi-
tional views on the neural control of the sympathetic and
somatomotor systems have posited that these are regu-
lated by very different neural networks. In such a scheme
the somatic motor system is viewed to be largely under
voluntary control and is regulated by voluntary action
(Cannon, 1963). In contrast, the function of the internal
viscera is viewed as largely outside of the willful control of
the body and was thought to be regulated subconsciously
by the sympathetic and parasympathetic arms of the au-
tonomic nervous system (Langley, 1921; Cannon, 1963).
More recent anatomical investigations have challenged
this notion and have provided evidence against this arbi-
trary separation between somatomotor and autonomic
systems. Specifically, Holstege (1995) suggested the exis-
tence of an emotional motor system, which coordinates
somatic motoneuron activity as part of emotionally moti-
vated behaviors. Work in our laboratory has sought to
extend these findings by directly addressing the question
of whether neurons with dual sympathetic and somatomo-
tor functions exist. Using genetically engineered strains of
the pseudorabies virus (PRV), we previously identified
distinct populations of neurons that simultaneously send
transsynaptic projections to the adrenal gland and the
gastrocnemius muscle; populations of such cells were dis-
tributed throughout the neuraxis and included areas in
the medulla, pons, midbrain, hypothalamus, and cortex
(Kerman et al., 2003, 2006).
A major brainstem area containing such
presympathetic-premotor neurons (PSPMNs) was located
within several nuclei that comprise the ventromedial me-
dulla, including the caudal raphe nuclei (raphe obscurus,
raphe pallidus, and raphe magnus), gigantocellular nu-
cleus pars alpha, and the ventral gigantocellular nucleus
(Kerman et al., 2003). These ventromedullary nuclei con-
tain large numbers of serotonergic neurons that send de-
scending projections to the spinal cord (Mason, 2001).
More rostrally, we identified another major cluster of
PSPMNs in the caudal portion of the ventrolateral peri-
aqueductal gray (Kerman et al., 2006). Similar to the
ventromedial medulla, this area has also been reported to
contain a population of serotonergic neurons (Steinbusch,
1981).
Taken together, these observations suggest that a sub-
set of the PSPMNs in the brainstem may use serotonin as
their neurotransmitter. To test this hypothesis we utilized
a previously developed paradigm for the identification of
PSPMNs by using virally mediated transsynaptic tract
tracing (Kerman et al., 2003, 2006) together with immu-
nofluorescent detection of tryptophan hydroxylase (TPH),
a key synthetic enzyme in the production of serotonin
(Nestler et al., 2001). Two isoforms of TPH have been
described, TPH1 and TPH2 (Walther et al., 2003); only the
latter is expressed in the brain (Patel et al., 2004). Thus,
to test our hypothesis we generated an antibody specific
for TPH2.
MATERIALS AND METHODS
All of the procedures regarding animal use in this study
conformed to the Guide for the Care and Use of Laboratory
Animals (1996, National Academy of Sciences) and were
approved by the University of Michigan’s University Com-
mittee on Use and Care of Animals.
Design and characterization of the TPH2
antibody
Our initial experiments were aimed at designing an
antibody against TPH and then validating the specificity
of its binding in paraformaldehyde-fixed rat tissue. The
TPH1 isoform is preferentially expressed in the periphery
and the pineal gland, while TPH2 is expressed within the
brainstem raphe nuclei (Walther et al., 2003; Patel et al.,
2004). To avoid crossreactivity with other hydroxylases,
our antibody was designed specifically to avoid the active
core of TPH2. Instead, it targeted a unique span of the
N-terminal region: Phe-Ser-Leu-Asp-Ser-Ala-Val-Pro-
Glu-Glu-His-Gln, which was crosslinked to thyroglobulin
using glutaraldehyde. The antibody was raised by injec-
tion of the conjugated peptide into a rabbit. Serum was
then collected and booster inoculations were administered
every 6 weeks. The current experiments were carried out
with serum obtained from the sixth bleed, which was
affinity-purified. Specificity of the rabbit anti-TPH anti-
body was confirmed in adult male Sprague-Dawley rats
(n  2; Charles River Laboratories, Wilmington, MA). In
these experiments the animals were deeply anesthetized
with 1–1.5 mL intraperitoneal (i.p.) of 50 mg/mL pento-
barbital sodium solution. Rats were then transcardially
perfused with 100–150 mL of physiological saline followed
by 400–500 mL of Zamboni’s fixative (1.8% paraformalde-
hyde, 0.075% of picric acid in 0.17 M phosphate buffer,
PB). Brains were then extracted, 10-m brain sections
were cut on a cryostat at 20°C, and mounted on Super-
frost slides (Fisher Scientific, Pittsburgh, PA) immedi-
ately after sectioning. TPH2 antibody was reacted with
the tissue at multiple concentrations and the optimal di-
lution was empirically determined. Using the nickel-
enhanced horseradish peroxidase diaminobenzidine visu-
alization procedure the optimal dilution of the antibody
was 1:2,000. The distribution pattern of TPH2 immunore-
activity was examined under control conditions and under
conditions when the antibody was preincubated with var-
ious peptides. In these experiments adjacent sections were
incubated with the TPH2 antibody and with the TPH2
antibody solution preincubated with 2 M and 5 M of the
TPH2 peptide (see sequence above). In similar experi-
ments, adjacent sections were incubated the TPH2 anti-
body and with the TPH2 antibody solution preincubated
with 2 M and 5 M of TPH1 peptide (Met-Ile-Glu-Asp-
Asn-Lys-Glu-Asn-Lys-Asp-His-Ser-Leu-Glu-Arg) or prein-
cubated with 1 M or 50 M of Ki-67 (Thr-Pro-Lys-Glu-
Lys-Ala-Gln-Ala-Leu-Glu-Asp-Leu-Ala-Gly-Phe-Lys-Glu-
Leu-Phe-Gln-Thr-Pro), an unrelated peptide.
To determine the fraction of TPH2-positive cells within
the different nuclei, one adult male Sprague-Dawley rat
was deeply anesthetized with 1 mL i.p. of 50 mg/mL pen-
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tobarbital sodium solution and then transcardially per-
fused with 150 mL of physiological saline followed by 500
mL of a 4% paraformaldehyde solution containing 1.4%
L-lysine and 0.2% sodium meta-periodate (PLP fixative)
(McLean and Nakane, 1974). The brain was then ex-
tracted, postfixed overnight, immersed in 30% sucrose
until it sank, and cut on a freezing microtome at a thick-
ness of 40 m. A 1-in-6 series was then reacted with the
TPH2 antibody at a concentration of 1:2,000 overnight
and visualized with diaminobenzidine. The sections were
then mounted on glass slides, counterstained with cresyl
violet, dehydrated in graded alcohols, defatted in xylene,
and coverslipped with Permount (Fisher Scientific).
Overview of tract-tracing studies
Male Sprague-Dawley rats (n  6) (Charles River Lab-
oratories, Wilmington, MA) were used in tract-tracing
studies. In these experiments we employed transgenic
recombinants of an attenuated PRV strain, PRV-Bartha,
for transneuronal tracing of multisynaptic pathways in-
nervating adrenal gland and gastrocnemius muscle. PRV
has preferential tropism for axonal terminals (Vahlne et
al., 1978, 1980). It is transported in the retrograde direc-
tion from the terminals to the cell body where the viral
genome is replicated in the nucleus (Enquist et al., 1998).
Capsids are assembled and filled with viral DNA in the
nucleus, acquire the mature envelope from a late Golgi
compartment, and are transported to sites of afferent syn-
aptic contact where cell-to-cell retrograde transneuronal
transmission of infection occurs (Card et al., 1993; Enquist
et al., 1998). The two viral recombinants that we employed
were PRV-152 and PRV-BaBlu. Both are derived from
PRV-Bartha, which is an attenuated form of the parental
strain, PRV-Becker. PRV-BaBlu contains the lac Z gene at
the gG locus and produces -galactosidase (-gal) under
the control of the viral gG promoter (Kim et al., 1999).
PRV-152 carries the gene coding for enhanced green flu-
orescent protein (eGFP) at the gG locus, which is consti-
tutively expressed under control of the cytomegalovirus
immediate early promoter (Smith et al., 2000). Previous
studies have demonstrated that PRV-152 and PRV-BaBlu
are transported transsynaptically in a retrograde manner,
similar to PRV-Bartha, and that the two recombinants are
capable of simultaneously coinfecting the same neuronal
population (Standish et al., 1995; Billig et al., 1999, 2000,
2001; Smith et al., 2000; Kerman et al., 2003, 2006).
We previously reported a robust negative correlation
between an animal’s weight and efficiency of infection of
gastrocnemius motoneurons, with the largest rate of mo-
toneuron infection in rats of intermediate size that weigh
200 g (Kerman et al., 2003). Thus, animals in the cur-
rent study were selected to weigh between 163 and 240 g
for an average of 194  13 g (mean  SEM; weighed at
time of sympathectomy (see below)). Animals were anes-
thetized with 5% isoflurane vaporized in 1–1.5 L/min of
O2, and maintained with a 1.5–2.5% concentration. Once a
surgical plane of anesthesia was achieved such that there
was no spontaneous movement and there were no with-
drawal responses to tail and/or foot pinch, hindlimb sym-
pathectomy was performed.
In addition to somatic motor efferents, the hindlimb is
also innervated by sympathetic efferents that project to
blood vessels, sweat glands, and other smooth muscle
targets (Jänig and McLachlan, 1992). To prevent infection
of sympathetic pathways following injection of PRV-152
into the gastrocnemius muscle, the hindlimb was surgi-
cally sympathectomized in all animals using a previously
described approach (Kerman et al., 2003). Briefly, the
lumbar sympathetic nerve was dissected via a ventral
laparotomy and was extirpated from the level of the renal
artery caudal to the bifurcation of the abdominal aorta.
Neural plexuses running along the descending aorta and
inferior vena cava were also stripped off under microscopic
observation using fine forceps. The abdominal aorta and
the inferior vena cava were then swabbed with 10–20%
phenol dissolved in ethylene glycol. The abdominal mus-
culature was closed with sutures and the overlying skin
was closed with surgical staples. This procedure is effec-
tive at removing the large majority of sympathetic effer-
ents to the hindlimb, as evidenced by the lack of infection
in the intermediolateral cell column in the same animals
that exhibited robust infections of lumbar motoneurons
(Kerman et al., 2003, 2006).
Following sympathectomy and a 2–10 day recovery pe-
riod the animals were reanesthetized. Due to supply prob-
lems some of the animals (n  2) were anesthetized with
an i.p. injection of ketamine and xylazine mixture (60
mg/kg ketamine and 7 mg/kg xylazine), while the remain-
ing animals were anesthetized using an isoflurane proto-
col as described above. After a surgical plane of anesthesia
was achieved the animals were injected with PRV-152 into
their gastrocnemius muscle.
Following PRV-152 injections and a 24–32-hour recov-
ery period the same rats were reanesthetized with either
isoflurane (n  4) or a ketamine and xylazine mixture (n 
2) and were injected with PRV-BaBlu into the adrenal
glands. Choice of anesthetic regime had no effect on viral
infection or transport.
At the conclusion of the survival period following trans-
port of viral tracers, animals were deeply anesthetized
with 1 mL i.p. of 50 mg/mL pentobarbital sodium solution
and transcardially perfused with 100–150 mL of physio-
logical saline followed by 400–500 mL of PLP fixative.
Double-virus injections
Viral recombinants used in the present studies were
harvested from pig kidney cell cultures at a titer of 108–
109 pfu/mL. Viral stocks were aliquoted in 50-L volumes
and stored at 80°C. At the times of injection viral ali-
quots were removed from the freezer and kept on ice until
immediately before injections.
To determine the location of neurons coordinating mus-
cle contraction and autonomic activity, rats received injec-
tions of PRV-152 into their left (n  4) or right (n  2)
gastrocnemius muscle and injections of PRV-BaBlu into
their left adrenal gland (n  6). The gastrocnemius muscle
was injected with 30 L of PRV-152, which was divided
into multiple injections of 1.0 L. The adrenal gland was
dissected via a left flank incision and gently separated
from surrounding viscera and fat; the adjacent connective
tissue was then retracted to facilitate access to the gland.
Two or three injections of PRV-BaBlu were then made into
the gland through a glass pipette attached to a 10-L
Hamilton syringe; the total volume of virus injected was
2–4 L. Following each injection the gland was swabbed
with a cotton-tip applicator to decrease nonspecific viral
spread. We previously demonstrated that this injection
protocol produces an efficient infection of target neurons
and does not result in spread of virus to nontarget tissues
(Kerman et al., 2003).
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Injected animals were assigned to one of three groups:
short, intermediate, and long survival times. In the short
survival group (n  2) rats survived 121–122 hours fol-
lowing injections with PRV-152 and 96–97 hours follow-
ing PRV-BaBlu injections. We chose these survival time
points because this is one of the earliest time points at
which appreciable numbers of double-infected neurons are
detected in the ventromedial medulla in the rat (Kerman
et al., 2003, 2006). Since a single replication cycle of the
virus is 10–12 hours (Demmin et al., 2001), we therefore
decided to extend the survival times by 10–12 hours to
determine the maximal number of double-infected neu-
rons that express TPH2. Accordingly, in the intermediate
survival group (n  2) the animals survived 132 and 108
hours following injections with PRV-152 and PRV-BaBlu,
respectively. In the late survival group (n  2) the animals
survived 144 and either 112 or 120 hours following injec-
tions with PRV-152 and PRV-BaBlu, respectively.
Tissue processing
Following transcardial perfusion with PLP (see above),
the entire brain was extracted and postfixed in PLP over-
night. Brains were then immersed in 30% sucrose until
they sank to the bottom of the container and sectioned
coronally on a freezing microtome at a thickness of 35 or
40 m and collected into six bins. Tissue was stored at
20°C in cryoprotectant (30% sucrose, 30% ethylene gly-
col, 1% polyvinyl-pyrrolidine (PVP-40)) until immunohis-
tochemical processing was conducted.
In two animals (both in the short survival group) tho-
racic and lumbar spinal cords were also collected. In these
animals spinal cord was extracted in three blocks: T1–T7
segment, T8–T13, and L1–L6. These blocks were then
sectioned in the horizontal plane at 35 or 40 m. A one-
in-three series for each block was processed for simulta-
neous visualization of PRV-152 and PRV-BaBlu using im-
munofluorescent methods aimed at the detection of eGFP
and -gal (see below for methodological details).
For immunofluorescent detection in the brain, tissue
was initially rinsed with 0.1 M PB (pH 7.4) several times
at room temperature. It was then incubated for 1 hour in
a blocking solution made up of 1% normal goat serum
(NGS), 1% bovine serum albumin (BSA), and 0.3% Triton
X-100 (TX-100) in 0.1 M PB. Sections were then reacted
with a cocktail of primary antibodies: chicken anti-GFP
IgY (Abcam, Cambridge, MA, product 13970) at 1:2,000,
mouse anti--gal IgG (Sigma, St. Louis, MO, product
G4644) at 1:1,000, and rabbit anti-TPH2 at 1:500, diluted
in the above blocking solution. The chicken anti-GFP an-
tibody was raised against recombinant full-length protein.
This antibody yields a single band on Western blot and
detects GFP in transgenic mice expressing GFP in lamina
II of the spinal cord (manufacturer’s technical informa-
tion). In our preliminary experiments we demonstrated
the absence of staining with this antibody in uninfected
rat tissue sections. Mouse anti--gal antibody was devel-
oped in mouse peritoneal cavities using -gal purified
from E. coli as the immunogen. Using Western blot, this
antibody was shown to be specific for -gal in its native
form (116 kD), and it reacts only with -gal from E. coli
(manufacturer’s technical information). Specificity of this
antibody in immunofluorescent experiments has been pre-
viously documented (Kerman et al., 2003).
Following a 24–48-hour incubation at 4°C in the pri-
mary antibody solution, the tissue was rinsed several
times with 0.1 M PB and then reacted with a secondary
antibody solution, which consisted of donkey anti-mouse
IgG conjugated to CY3 (1:200; Jackson ImmunoResearch,
West Grove, PA), goat anti-chicken IgG conjugated to Al-
exaFluor488 (1:200; Molecular Probes, Eugene OR, In-
vitrogen, La Jolla, CA) and biotinylated goat anti-rabbit
IgG (Vector Laboratories, Burlingame, CA) dissolved in
the blocking solution (1% NGS, 1% BSA, and 0.3% TX-
100). Tissue sections were then briefly rinsed and then
incubated with NeutrAvidin conjugated to AlexaFluor350
(1:200; Molecular Probes, Invitrogen). Thus, PRV-152-
infected cells appeared green, those infected with PRV-
BaBlu were red, while TPH2-positive neurons were blue.
Neurons double-infected with PRV-152 and PRV-BaBlu
appeared either yellow or orange, depending on the bal-
ance of colors. Double-infected cells that colocalized with
TPH2 would theoretically be white, since blue, green, and
red represent the full spectrum of visible light. However,
because of the differences in the balance and intensity of
each color, triple-labeled cells were close to white in color
with a bluish, reddish, or greenish tinge to them. Follow-
ing processing, tissue sections were mounted on glass
slides and coverslipped with Aqua Poly/Mount (Poly-
sciences, Warrington, PA).
For immunofluorescent detection in the spinal cord a
similar protocol was used. Tissue was initially rinsed with
0.1 M PB several times at room temperature. It was then
incubated for 1 hour in a blocking solution made up of 1%
normal donkey serum, 1% BSA, 0.3% TX-100 in 0.1 M PB.
The tissue was then reacted with a cocktail of primary
antibodies: rabbit anti-GFP IgG (Molecular Probes) at
1:1,000 and mouse anti--gal IgG (Sigma) at 1:1,000, di-
luted in the above blocking solution. Following a 24–48-
hour incubation at 4°C in the primary antibody solution
the tissue was rinsed several times with 0.1 M PB and
then reacted with a secondary antibody solution, which
consisted of donkey anti-mouse IgG conjugated to CY3
(1:200; Jackson ImmunoResearch) and goat anti-rabbit
IgG conjugated to BODIPY FL (1:200; Molecular Probes)
dissolved in the blocking solution. Thus, PRV-152-infected
cells appeared green, while those infected with PRV-
BaBlu were red. Specificity of the primary and secondary
antibodies employed in these double-labeling experiments
has been previously documented (Billig et al., 2000; Ker-
man et al., 2003).
Tissue analysis
Tissue was examined using a Leica DMR photomicro-
scope (Wetzlar, Germany). The rat atlas of Paxinos and
Watson (1986) was used as a reference for anatomical
classification. Infected neurons were digitized using a
Photometrics CoolSNAPfx black-and-white camera (Tuc-
son, AZ) and MCID Elite 7.0 imaging software (Imaging
Research, St. Catharines, Ontario). The presence of each
fluorophore was detected using specific filter sets (Chroma
Technology, Brattleboro, VT) with the following respective
excitation and emission ranges: AlexaFluor350: 320–400
nm and 410–510 nm (blue fluorescence), AlexaFluor488
and BODIPY FL: 440–520 nm and 500–555 nm (green
fluorescence), and CY3: 535–560 nm and 545–625 nm (red
fluorescence).
Adjacent black-and-white images of the region of inter-
est were digitized under a 20 objective using a manually
driven stage equipped with a Leica Sensor Control Dis-
play (Märzhäuser SensoTech, Wetzlar, Germany) to
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record stage coordinates. We took several high-power im-
ages through the region of interest. In order to visualize
the entire area, high-power images were stitched together
using the Photomerge function in Adobe Photoshop v. 8.0
(Adobe Systems, San Jose, CA). Each of these large
stitched images corresponded to a different fluorescent
filter set and was pseudocolored as follows: GFP-positive
neurons, green; -gal-containing cells, red; and TPH2-
positive neurons, blue. These pseudocolored images were
then overlaid and colocalization of two or three fluoro-
phores was determined by turning on and off each layer to
determine the location and color of each cell.
Neurons expressing different combinations of signals
and located within different brainstem nuclei were man-
ually counted from the Photoshop files. Neurons were
quantified from six different levels through medulla and
midbrain at approximately 12.7 mm, 11.6 mm, 11.0
mm, 10.3 mm, 8.7 mm, and 7.8 mm relative to
bregma. Since not every nucleus was present at each level,
different numbers of sections were used to quantify the
data for each nucleus. Quantification was performed from
one section/animal for the caudal, dorsal, ventral, and
ventrolateral subdivisions of the dorsal raphe, one section/
animal for ventrolateral periaqueductal gray, one section/
animal for the parapyramidal area, two sections/animal
for raphe obscurus, three sections/animal for gigantocel-
lular nucleus pars alpha (ventral and dorsal subdivisions),
three sections/animal for raphe magnus, and four
sections/animal for raphe pallidus.
To determine fractions of serotonergic cells in different
nuclei, tissue in which TPH2 antibody was visualized with
diaminobenzidine and counterstained with cresyl violet
was used. Cell counts were performed using Stereo Inves-
tigator 6.5 software (MicroBrightField, Williston, VT) un-
der a 40 objective. The total number of cells in each
nucleus was determined by counting nuclei of all cresyl
violet-stained cells and TPH2-positive profiles.
Brightness and contrast of images were optimized for
presentation purposes, and figures were prepared in Pho-
toshop.
RESULTS
Specificity of TPH2 antibody
To ascertain the specificity of the TPH2 antibody used
in these studies we carried out blocking studies with
TPH1, TPH2, and Ki-67 peptides. Under control condi-
tions, in the absence of peptide, there was robust labeling
within the dorsal raphe (DR) in the midbrain (Fig.
1A,D,G) but not in the pineal gland (data not shown). This
labeling was markedly attenuated when the antibody so-
lution was preadsorbed with 2 M solution of the TPH2
peptide (Fig. 1B). The labeling was blocked entirely when
the concentration of the TPH2 peptide was increased to 5
M (Fig. 1E). In contrast, preadsorption of the antibody
solution with TPH1 peptide had no effect on the signal
intensity either at 2 or 5 M (Fig. 1C,F). Similarly, pread-
sorption with Ki-67, an unrelated peptide, had no effect on
the immunocytochemical labeling within the dorsal raphe
(Fig. 1H,I).
Distribution of TPH2-positive neurons
The distribution of TPH2-positive neurons was exam-
ined within the medulla, pons, and midbrain. In the me-
dulla, TPH2-positive neurons were found within a midline
column of cells comprised of raphe pallidus (RPa) and
raphe obscurus (ROb; Fig. 2A,B, respectively). At more
rostral levels, TPH2-positive neurons appeared more lat-
erally within raphe magnus (RMg; Fig. 2D), gigantocellu-
lar nucleus pars alpha (GiA; Fig. 2E), as well as the
parapyramidal cell group (PPy; Fig. 2C), located dorsolat-
erally to the pyramidal tracts. Within GiA, TPH2-positive
neurons were preferentially distributed along the ventral
aspect of the nucleus. At the level of the pontomedullary
junction, TPH2-immunoreactive neurons were found pri-
marily within RMg and RPa (Fig. 2G) and GiA (Fig. 2F).
TPH2-immunoreactive neurons in the midbrain were
concentrated primarily along the midline within DR and
median raphe (MnR; Fig. 3A,C). Additionally, such neu-
rons were also located within laterally displaced clusters
within the ventrolateral periaqueductal gray (vlPAG; Fig.
3B,D).
The fraction of serotonergic neurons in each nucleus
was estimated from the material in which TPH2 was
visualized with diaminobenzidine and the tissue was
counterstained with cresyl violet. In these experiments,
the total number of cells was estimated from all detectable
cresyl violet-stained nuclei. This quantification revealed
considerable variability in the fraction of serotonergic
neurons among the different nuclei. These values ranged
from 5–33%, depending on the nucleus (Table 1).
Labeling in the spinal cord
Labeling in the spinal cord was examined in two rats in
the short survival group. The goals of these experiments
were: 1) to verify the effectiveness of the surgical sympa-
thectomy, and 2) to verify infection of the appropriate
first-order neurons in thoracic and lumbar spinal cord. In
both animals we detected infection in the ipsilateral gas-
trocnemius motoneurons with PRV-152 at L3–L4 levels of
the spinal cord (Fig. 4A). We also observed infection of
ipsilateral adrenal sympathetic preganglionic neurons
within the intermediolateral cell column at mid-thoracic
levels with PRV-BaBlu (Fig. 4B). There was no infection
with PRV-152 in the intermediolateral cell column (Fig.
4C), demonstrating the effectiveness of the surgical sym-
pathectomy.
Expression of TPH2 within PSPMNs
As in our previous studies, we found considerable clus-
ters of PSPMNs within the different subregions of the
ventromedial medulla, including ROb, RMg, RPa, GiA,
and PPy (Figs. 5–7). At more rostral levels, clusters of
PSPMNs were also found within vlPAG and just lateral to
the DR proper (Fig. 8). This basic distribution pattern was
the same for animals at different survival times; however,
the numbers of double-infected neurons increased with
longer survival times (Figs. 6–8). Triple- and double-
labeled neurons were found throughout the brainstem and
included neurons within the ventromedial medulla, pons,
and caudal midbrain (Fig. 5).
To estimate whether specific nuclei may vary in their
content of triple-labeled neurons, we mapped the locations
of double- and triple-labeled cells in each animal at six
different rostrocaudal levels (Figs. 6–8). This analysis
revealed distinct clustering of neurons infected with one
or both strains of PRV that also expressed TPH2. At the
caudalmost level that we examined (12.7 mm from
bregma), such neurons were confined primarily to ROb
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and distributed along the midline (Figs. 5C, 6A). At the
more rostral levels within medulla-pons (11.6 mm,
11.0 mm, and 10.3 mm from bregma), these neurons
fanned out laterally and ventrally and were concentrated
within the ventral aspect of GiA and to some extent within
RMg and PPy (Figs. 6B,D, 7). Few of the virus-infected
neurons in the midbrain expressed TPH2 at the early
survival times. However, at the longer survival times
their numbers increased and they were displaced laterally
from the midline and found predominantly within vlPAG
(Fig. 8C) and lateral DR (Fig. 8D).
Estimates of the number of these cells among the dif-
ferent nuclei revealed differences in their distribution. At
the caudal levels the greatest numbers of TPH2-positive
PSPMNs were found within ROb, RMg, and GiA (Table 1).
At more rostral levels, relatively low numbers of TPH2-
positive PSPMNs were detected in the different subdivi-
sion of DR and in the vlPAG (Table 1).
Additionally, we estimated the percentage of PSPMNs
that expressed TPH2 within the different nuclei. This
analysis revealed that these neurons were enriched in the
ventral GiA (Table 1). In contrast, dorsal GiA contained a
relatively low percentage of TPH2-positive PSPMNs (Ta-
ble 1).
DISCUSSION
In the current study we focused our attention on brain-
stem PSPMNs. Neurons with putative dual (sympathetic
and somatomotor) functions were identified by injections
of distinct PRV recombinants into peripheral muscle and
the adrenal gland. Based on our previous reports on the
anatomical distribution of the brainstem PSPMNs, we
hypothesized that a subset of them would be serotonergic.
To test this hypothesis, we designed and produced an
antibody against TPH2, a TPH isoform that is specifically
Fig. 1. Characterization of tryptophan hydroxylase 2 (TPH2) an-
tibody. Specificity of binding was ascertained by performing a series of
blocking studies. In the first experiment signal was examined under
control conditions when tissue was reacted with TPH2 antibody at
1:2,000 (A). Adjacent sections were then reacted with TPH2 antibody
pre-adsorbed with 2 M of either TPH2 (B) or TPH1 (C) peptide
solution. In the second experiment TPH2 signal (at 1:2,000) was
examined under control conditions (D) and after preadsorption of the
antibody with 5 M of either TPH2 (E) or TPH1 (F) peptide. In the
last experiment TPH2 signal (at 1:2,000) was examined under control
conditions (G) and after preadsorption of the antibody with either 1
M (H) or 50 M (I) of Ki-67 (an unrelated peptide). Scale bar  100
m.
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Fig. 2. Distribution of tryptophan hydroxylase-positive neurons in
the medulla-pons. Drawings on the left were adapted from the Paxi-
nos and Watson (1986) rat brain atlas and illustrate anatomical
locations of photomicrographs on the right. Solid boxes in the left
column correspond to panels on the right. Numbers on the left refer to
approximate distance from bregma in mm. GiA, gigantocellular nu-
cleus pars alpha; IO, inferior olive; py, pyramidal tract; PPy, parapy-
ramidal cell group; RMg, raphe magnus; ROb, raphe obscurus; RPa,
raphe pallidus. Scale bars  50 m.
expressed in the brain (Patel et al., 2004). Our character-
ization studies of this antibody demonstrate that the
staining produced by this antibody is specific for TPH2
since: 1) the signal was completely blocked by the specific
TPH2 peptide but not by TPH1 or Ki-67 peptides, and 2)
distribution of immunopositive neurons closely matched
the distribution of TPH2 mRNA (Patel et al., 2004). Thus,
we could be confident that the neurons that we detected
with this antibody were serotonergic.
Our injections into the muscle and adrenal gland were
effective at infecting specific first-order neurons, as dem-
onstrated by the labeling in the spinal cord. Injections of
PRV-BaBlu into the adrenal gland produced infection of
ipsilateral sympathetic preganglionic neurons at mid-
thoracic levels. This distribution of putative adrenal sym-
pathetic preganglionic neurons is in close agreement with
previous studies that demonstrated that these neurons
are distributed from T4 to T12 in the spinal cord (Strack et
al., 1989; Li et al., 1992; Joshi et al., 1995). Likewise, we
detected PRV-152-infected somatic motoneurons at ipsi-
lateral mid-lumbar spinal levels, which most likely repre-
sent gastrocnemius motoneurons since these cells were
detected in the same location in previous investigations
(Hashizume et al., 1988; Kanda et al., 1989; Kerman et al.,
2003). Furthermore, we can be confident of the effective-
ness of the surgical sympathectomy procedure since we
did not observe infection with PRV-152 in the intermedio-
lateral cell column in the same animals that showed ro-
bust infection of gastrocnemius motoneurons, which is
also consistent with our past findings (Kerman et al.,
2003, 2006).
We found considerable overlap between the distribution
of TPH2-positive cells and PSPMNs. The distribution of
TPH2-expressing PSPMNs differed along the rostrocaudal
extent, with peaks in the rostral medulla and at the pon-
tomedullary junction. Likewise, the distribution of these
cells differed by nuclei so that ROb, RMg, and GiA con-
tained the greatest numbers of triple-labeled neurons. The
fraction of PSPMNs that were TPH2-positive also differed
by nuclei. Interestingly, within GiA there was a difference
in the location of triple-labeled cells in the dorsoventral
extent, with a much greater percentage of such cells lo-
cated within its ventral compartment. This is consistent
with the recent findings of Toth et al. (2006), who found a
differential distribution of serotonergic neurons that in-
nervate the tail in this region. Those authors demon-
strated that presympathetic serotonergic cells that inner-
vate the tail are preferentially distributed toward the
ventral edge of the ventromedial medulla, with large num-
bers located just dorsal to the pyramids (Toth et al., 2006).
This finding is in agreement with our data that indicate
that a large fraction of serotonergic PSPMNs are located
Fig. 3. Distribution of tryptophan hydroxylase-positive neurons in
the midbrain. The figure layout is similar to that of Figure 2. aq,
central aqueduct; vlDR, ventrolateral subdivision of the dorsal raphe;
vlPAG, ventrolateral periaqueductal gray. Scale bars  50 m.
TABLE 1. Fractions of Tryptophan Hydroxylase 2 (TPH2)-Positive
Presympathetic-Premotor Neurons (PSPMNs), and Fractions of TPH2-


















dDR 2 13 15 24 (652)
cDR 3 12 25 21 (505)
vlPAG 6 84 7 12 (615)
vDR 9 19 47 30 (417)
vlDR 15 75 20 11 (287)
PPy 12 51 24 6 (391)
RPa 7 15 47 33 (134)
ROb 27 102 26 12 (829)
dGiA 12 71 17 5 (296)
vGiA 21 37 57 12 (306)
RMg 23 97 24 19 (273)
Estimates of the total number of cells per section in each nucleus was derived from
cresyl violet-stained sections, indicated in parentheses. Numbers represent totals from
all animals normalized to the number of sections used to sample through each nucleus
per animal.
cDR, caudal dorsal raphe; dDR, dorsal subdivision of dorsal raphe; dGiA, dorsal gigan-
tocellular nucleus pars alpha; PPy, parapyramidal cell group; RMg, raphe magnus;
ROb, raphe obscurus; RPa, raphe pallidus; vDR, ventral subdivision of dorsal raphe;
vGiA, ventral gigantocellular nucleus pars alpha; vlDR, ventrolateral dorsal raphe.
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within ventral GiA as well as with studies that used
monosynaptic tracers and found preferential distribution
of spinally projecting serotonergic neurons in the ventral
GiA (Skagerberg and Björklund, 1985; Bowker and Ab-
bott, 1990; Jones and Light, 1992).
When interpreting our quantitative data it is important
to keep in mind that these numbers represent estimates.
To obtain more precise data with regard to the total num-
ber of TPH2-positive PSPMNs within different nuclei will
require more extensive unbiased 3D sampling. Nonethe-
less, our current estimates suggest differences in the dis-
tribution of serotonergic PSPMNs within the brainstem.
Based on our findings, we hypothesize that these sero-
tonergic PSPMNs likely project directly to the spinal cord,
and that these projections probably collateralize to simul-
taneously innervate adrenal sympathetic preganglionic
neurons in the thoracic spinal cord and gastrocnemius
motoneurons in the lumbar spinal cord. This notion is
supported by the fact that we detected TPH2-expressing
PSPMNs at the earliest survival time examined in this
study. We have previously reported the presence of
double-infected neurons in the ventromedial medulla at
an even earlier (96-hour postinjection into the gastrocne-
mius muscle) survival time point (Kerman et al., 2003).
Furthermore, studies employing classical tract-tracing
agents have demonstrated direct projections from the ven-
tromedial medulla to the intermediolateral cell column as
well as to the ventral horn of the spinal cord in different
species (Martin et al., 1979, 1985; Zemlan et al., 1984;
Holstege and Kuypers, 1987; Allen and Cechetto, 1994).
Others have also demonstrated the presence of serotoner-
gic terminals on motoneurons and sympathetic pregangli-
onic neurons (Appel et al., 1986, 1987; Wu et al., 1993) as
well as a high density of serotonergic fibers in the lumbar
ventral horn and the intermediolateral cell column (Stein-
busch, 1981). However, given the fact that we used a
transsynaptic tracer we cannot conclude with certainty
that these cells send direct projections to the spinal cord.
Future work utilizing monosynaptic tracers will be re-
quired to test this hypothesis.
In contrast, relatively fewer triple-labeled neurons were
found within the midbrain. Despite the presence of an
appreciable number of double-infected neurons, a lesser
fraction of PSPMNs was TPH2-positive, especially at the
earlier survival times. Nonetheless, our data demonstrate
a distinct clustering of TPH2-positive PSPMNs within the
vlPAG and vlDR at the later survival times. It is unlikely
that these neurons send direct projections to the spinal
cord, since their presence is not detected until the later
survival times. Instead, it is possible that these cells send
projections to the ventral medulla to simultaneously reg-
ulate sympathetic and somatomotor functions. This notion
is consistent with traditional tract-tracing experiments
that have demonstrated projections from the ventral and
ventrolateral periaqueductal gray to the ventromedial me-
dulla (Beitz et al., 1983; Van Bockstaele et al., 1991; Beitz,
1995; Farkas et al., 1998).
Fig. 4. Labeling in the spinal cord following PRV injections into
gastrocnemius muscle and adrenal gland. In the same animal we
observed PRV-152-infected somatic motoneurons at L4 spinal level
ipsilateral to the injected side (A) as well as PRV-BaBlu-infected
sympathetic preganglionic neurons in the ipsilateral intermediolat-
eral cell column at T8 (B). These neuronal populations correspond to
the gastrocnemius motoneuron pool and adrenal sympathetic pregan-
glionic neurons, respectively. Effectiveness of the surgical sympathec-
tomy was confirmed by the absence of PRV-152-infected neurons in
the intermediolateral cell column, an example at the ipsilateral T13 is
shown (C). Scale bar 100 m.
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Taken together, our data demonstrate the presence of
clusters of serotonergic PSPMNs within the rostral me-
dulla and at the medullopontine junction. Previous
studies have investigated the fraction of spinally pro-
jecting neurons from the ventromedial medulla that are
serotonergic. These estimates have ranged from 30 –
60% (Skagerberg and Björklund, 1985; Jones and Light,
1992) of spinally projecting neurons that are serotoner-
gic to over 90% of such cells (Bowker and Abbott, 1990).
Our data (see Table 1) suggest that in ROb and RMg
20 –30% of PSPMNs are serotonergic, while in RPa
and ventral GiA this fraction is 40 – 60%. These data
may actually underestimate the true fraction of TPH2-
expressing PSPMNs since viral infection inhibits tran-
scription of the host cell genome (Card, 2001). Nonethe-
less, these are heterogeneous nuclei that contain
neurons of multiple phenotypes. For example, the ven-
tromedial medulla has prominent expression of glu-
tamic acid decarboxylase (GAD) (Stornetta and Guy-
enet, 1999), a key synthetic enzyme in the production of
GABA, as well as vesicular glutamate transporters (Na-
kamura et al., 2004), suggesting that there are popula-
tions of glutamatergic and GABAergic cells in this re-
gion. Additionally, cells within the ventromedial
medulla also express a number of peptidergic transmit-
ters, including enkephalin, thyrotropin-releasing hor-
mone, and substance P (Kerman et al., 2004). The pos-
sibility that the nonserotonergic PSPMNs within GiA
express GAD, glutamate, and/or peptide neurotransmit-
ters remains to be explored.
Fig. 5. Examples of colocalization of TPH2 with PRV-152 and
PRV-BaBlu. Different panels represent distinct nuclei within
medulla-pons and the midbrain. These include the parapyramidal cell
group (A), gigantocellular nucleus pars alpha (B), raphe obscurus (C),
raphe magnus (D), raphe pallidus (E), and the ventrolateral periaq-
ueductal gray (F). Neurons infected with PRV-152 (1) were also in-
fected PRV-BaBlu (2) and/or expressed TPH2 (3). Merged images (of
123) are in panels 4. Triple-labeled neurons are shown with ar-
rows, while double-labeled neurons are indicated with arrowheads.
Scale bar  20 m.
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To determine whether the proportion of TPH2-
positive PSPMNs is identical to the proportion of cells
that is serotonergic in each nucleus, we estimated the
latter from cresyl violet-counterstained tissue. These
estimates suggest that the fraction of cells in each nu-
cleus that is serotonergic ranges from 5–33%. These
numbers are consistent with previous estimates, which
found that 10 –30% of the medullary raphe cells are
serotonergic (Moore, 1981; Potrebic et al., 1994). These
estimates also suggest that the number of TPH2-
positive PSPMNs is not simply a reflection of the frac-
tion of serotonergic cells in each nucleus. For example,
within the ventral subdivision of GiA, 57% of PSPMNs
are serotonergic, while only 12% of all cells are seroto-
nergic (Table 1). Likewise, within ROb and PPy, 26%
and 24% of PSPMNs are serotonergic, respectively,
while the fraction of serotonergic neurons is 12% and
6%, respectively (Table 1). Thus, within many of the
Fig. 6. Distribution of double- and triple-labeled neurons within
the medulla. Anatomical landmarks were traced from original sec-
tions and locations of virus-infected cells were plotted onto these
maps. Only one hemisection is presented from each level, but the
pattern of labeling was symmetrical. Each symbol represents one
neuron on the actual section. Yellow squares represent neurons coin-
fected with PRV-152 and PRV-BaBlu, black circles: neurons coin-
fected with PRV-152 and PRV-BaBlu that also express TPH2; red
triangles: TPH2-containing neurons that are infected with PRV-
BaBlu; aqua diamonds: TPH2-containing neurons infected with PRV-
152. Panels on the left (A,B) are from animals that survived 122 and
97 hours following injections with PRV-152 and PRV-BaBlu, respec-
tively. Panels on the right (C,D) are from animals that survived 144
and 120 hours following injections with PRV-152 and PRV-BaBlu,
respectively. Numbers on the left represent approximate distance in
mm from bregma. py, pyramidal tract; RPa, raphe pallidus; ROb,
raphe obscurus; PPy, parapyramidal area; GiA, gigantocellular nu-
cleus pars alpha; RMg, raphe magnus.
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nuclei examined, PSPMNs are more likely to be seroto-
nergic than would be predicted by chance alone.
Functional considerations
Classically, the ventromedial medulla has been consid-
ered to be a pain modulatory area, since activation of this
region can produce antinociception (Mason, 2001). This
notion is supported by the connections of this region,
which include neurons with direct projections to the dorsal
horn (Mason, 2001). Our findings suggest that such an-
tinociceptive neurons are intermingled with PSPMNs
within the ventromedial medulla; thus, it is possible that
activation of this region may coordinate somatomotor, au-
tonomic, and sensory responses to acute pain stimuli.
Such a scenario would include activation of PSPMNs to
facilitate expression of appropriate somatomotor and au-
tonomic responses as well as concurrent activation of the
antinociceptive neurons for simultaneous pain modula-
tion. This is supported by the fact that activation of the
ventromedial medulla by injection of kainic acid or mor-
phine elicits immobility together with antinociception
(Morgan and Whitney, 2000). Although autonomic param-
eters were not measured in that study, our data suggest
that such manipulations may also lead to the secretion of
adrenal catecholamines. It is also likely that serotonergic
neurons of the ventromedial medulla contribute to antino-
ciception since they project to the dorsal horn (Mason,
2005), and application of serotonin receptor antagonists in
the ventromedial medulla attenuates antinociception
evoked by ventromedullary stimulation (Hammond and
Yaksh, 1984; Barbaro et al., 1985). However, this action
may be dependent on the behavioral state, such as the
phase of the sleep/wake cycle (Mason, 2001). Likewise,
serotonergic neurons of the ventromedial medulla identi-
fied in the present study may act to coordinate somatomo-
tor and sympathetic functions during responses to acute
pain stimuli.
Another functional possibility is that the serotonergic
PSPMNs are involved in mediating central responses to
exercise. Results of studies in awake behaving cats sug-
Fig. 7. Distribution of double- and triple-labeled neurons in the
medulla. Presentation format and abbreviations are the same as in
Figure 6. Panels on the left (A,B) are from animals that survived 122
and 97 hours following injections with PRV-152 and PRV-BaBlu,
respectively. Panels on the right (C,D) are from animals that survived
144 and 120 hours following injections with PRV-152 and PRV-BaBlu,
respectively. Numbers on the left represent approximate distance in
mm from bregma.
The Journal of Comparative Neurology. DOI 10.1002/cne
893SYMPATHO-SOMATOMOTOR CIRCUITRY AND TPH2
gest that a major role of the descending serotonergic sys-
tem is to increase excitability of spinal motoneurons and
to facilitate somatomotor output (Jacobs and Fornal,
1997). More recently, recordings from serotonergic neu-
rons in the caudal raphe nuclei of awake locomoting cats
suggest that the decreases in the firing of these neurons
may be related to the onset of central fatigue (Fornal et al.,
2006). Thus, the serotonergic PSPMNs may gate excitabil-
ity of lumbar motoneurons and adrenal sympathetic
preganglionic neurons to prevent excessive stress during
exercise.
The serotonergic PSPMNs identified in the present
study may also play a role in serotonin syndrome, an
adverse reaction to intoxication with agents that lead to
increased serotonin release such as selective serotonin
reuptake inhibitors (Boyer and Shannon, 2005). This con-
dition is often characterized by somatomotor disturbances
such as spasms, shivering, and myoclonus as well as au-
Fig. 8. Distribution of double- and triple-labeled neurons within
the midbrain. Anatomical landmarks were traced from original sec-
tions and locations of virus-infected cells were plotted onto these
maps. Symbols are the same as in Figure 6. A,B: Animals that
survived 122 and 97 hours following injections with PRV-152 and
PRV-BaBlu, respectively. C,D: Animals that survived 144 and 120
hours following injections with PRV-152 and PRV-BaBlu, respec-
tively. aq, central aqueduct; cDR, caudal dorsal raphe; dDR, dorsal
subdivision of the dorsal raphe; vDR, ventral subdivision of the dorsal
raphe; vlPAG, ventrolateral periaqueductal gray.
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tonomic signs such as hypertension, tachycardia, and hy-
perthermia (Boyer and Shannon, 2005). This notion is
consistent with the finding that disinhibition of the ven-
tromedial medulla in lightly anesthetized rats causes in-
creases in blood pressure, tachypnea, shivering, and an
elevation in the temperature of brown adipose tissue (Na-
son and Mason, 2004).
Thus, it is possible that under normal conditions sero-
tonergic PSPMNs may mediate physiological responses to
acute pain stimuli and exercise, while under pathological
conditions they may mediate symptoms of serotonergic
intoxication.
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